cp wire

CP Wire Articles

BridgeBio Pharma Raises $299.2 Million to Support Its Genetic Disease Development Programs

BridgeBio Pharma, a clinical-stage biopharmaceutical company focused on genetic diseases, today announced a new financing round of $299.2 million. The round was co-led by existing investors KKR... read more

Wed, 01/23/19 - 09:22 am
ENDRA Life Sciences to Enhance Ultrasound Offerings with AI and Machine Learning

ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRA), a developer of enhanced ultrasound technologies, has partnered and established a collaboration with the Ladak Laboratory at Western University,... read more

Tue, 01/22/19 - 10:53 am
Microbiome Report for Week Ending 1/12/19

4D pharma and MD Anderson Cancer Center... read more

Thu, 01/17/19 - 10:09 am
Pappas Life Science Ventures Raises New $85.7 million investment fund

According to this regulatory filing, Pappas has raised a new $85.7 million investment... read more

Thu, 01/17/19 - 09:35 am
European Commission Approves Janssen's Erleada for Patients at High Risk of Developing Metastatic Prostate Cancer
  • Erleada is also approved in the US for the treatment of non-metastatic castration-resistant prostate cancer


The Janssen Pharmaceutical Companies of Johnson & Johnson... read more

Wed, 01/16/19 - 09:52 am

Pages